SARACCO, Giorgio Maria
SARACCO, Giorgio Maria
SCIENZE MEDICHE
"Prevalence of diabetes mellitus immunologic marker in patients with chronic hepatitis C before and after interferon therapy"
1997-01-01 Durazzo M;Mariani M.G;Biava MA;Clerico A;D'Errico N;Sacchi C;Tabone M;Saracco G;Rizzetto M;Pagano G.
A NOVEL APPROACH FOR HEPATITIS DELTA VIRUS VIREMIA QUANTIFICATION BY DROPLET DIGITAL PCR ASSAY
2016-01-01 Olivero, A.; Abate, M.L.; Niro, G.; Caviglia, G.P.; Rosso, C.; Ciancio, A.; Fontana, R.; Smedile, A.; Rizzetto, M.; Saracco, G.M.
Absolute quantification of intrahepatic HBV covalently-closed-circular DNA by droplet digital PCR
2017-01-01 Gian Paolo Caviglia; Maria Lorena Abate; Antonella Olivero; Chiara Rosso; Alessia Ciancio; Elisabetta Bugianesi; Giorgio Maria Saracco; Antonina Smedile
Absolute quantification of intrahepatic hepatitis B virus covalently-closed-circular DNA by droplet digital PCR technology
2017-01-01 Caviglia, G.P.; Abate, M.L.; Olivero, A.; Rosso, C.; Ciancio, A.; Bugianesi, E.; Saracco, G.M.; Smedile, A.
Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease
2016-01-01 Marietti, M.; Rosso, C.; Gaggini, M.; Saponaro, C.; Kazankov, K.; Buzzigoli, E.; Holler, H.J.; Caviglia, G.P.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Vilstrup, H.; George, J.; Gronbaek, H.; Gastaldelli, A.; Bugianesi, E.
ALL ORAL SOFOSBUVIR-BASED ANTIVIRAL THERAPY IN LIVER TRANSPLANT RECIPIENTS AFFECTED BY MODERATE-SEVERE HEPATITIS C RECURRENCE: PREDICTORS OF VIRAL RESPONSE AND SURVIVAL
2016-01-01 Arese, D.; Martini, S.; Sacco, M.; Strona, S.; Cocchis, D.; Mirabella, S.; Rizza, G.; Ottobrelli, A.; Torrani-Cerenzia, M. R.; Balzola, F.; Magistroni, P.; Moschini, P.; Amoroso, A.; Salizzoni, M.; Rizzetto, M.; Romagnoli, R.; Saracco, G. M.
Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation
2016-01-01 Gastaldelli, A.; Gaggini, M.; Rosso, C.; Della Latta, V.; Marietti, M.; Caviglia, G.; Carli, F.; Buzzigoli, E.; Ciociaro, D.; Abate, M.; Smedile, A.; Saracco, G.; Bugianesi, E.
Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease
2016-01-01 Rosso, C.; Gaggini, M.; Saponaro, C.; Marietti, M.; Caviglia, G.P.; Carli, F.; Buzzigoli, E.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Gastaldelli, A.; Bugianesi, E.
Angiotensin II type 1 receptor inhibition in early stage cirrhotic patients: Effects on portal pressure and liver fibrosis
2004-01-01 MARTINI S; ALESSANDRIA C; DEBERNARDI VENON W; MARZANO A; BIASI F; LEONE N; BARLETTI C; TODROS L; G. POLI; SARACCO G; RIZZETTO M
Application of serum cytokeratin-19 fragments (CYFRA 21-1) in predicting the prognosis of patients with hepatocellular carcinoma
2020-01-01 Gian Paolo Caviglia, Antonella Olivero, Michela Ciruolo, Patrizia Carucci, Emanuela Rolle, Chiara Rosso, Maria Lorena Abate, Alessandra Risso, Ramy Younes, Antonina Smedile, Giorgio Maria Saracco, Elisabetta Bugianesi, Silvia Gaia
Autoantibodies to glutamic acid decarboxilase (anti-GAD) in patients with chronic hepatitis C.
1996-01-01 R.Gambino; G.Saracco; G.M.Mariani; A.Maccagnani; M.A.Biava; R.Arcari; M.Cassader; M.Durazzo
Autoimmunty in patients with chronic hepatitis type D and C
1994-01-01 Durazzo M,Schmidt E,Loges S,Michel G,Rosina F;Saracco G,Brunetto M-R,Smedile A,Scaglione L,Biava M-A,Borghesio E,Manns M-P,Rizzetto M
Basal values and on treatment decline of hepatitis B core-related antigen are predictive of response to interferon therapy in chronic hepatitis D
2018-01-01 A. Olivero, G.P. Caviglia, A. Ciancio, C. Bosco, R. Fontana, G. Niro, M. Rizzetto, G. M. Saracco, A. Smedile.
Basal values and on treatment decline of hepatitis B core-related antigen are predictive of response to interferon therapy in patients with chronic hepatitis D
2018-01-01 A. Olivero, G.P. Caviglia, A. Ciancio, C. Bosco, R. Fontana, G.A. Niro, M. Rizzetto , G.M. Saracco, A. Smedile
Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD
2018-01-01 C. Rosso, R. Younes, M. Eslam, FW. Chen, M. Cucco, M. Gaggini, S. Coulter, F. Carli, C. Barbieri, V. della Latta, M.L. Abate, GM. Saracco, A. Gastaldelli, J. George, E. Bugianesi
Characterization of a novel chemiluminescent enzyme immunoassay for the quantitation of antibodies to hepatitis B core antigen class IgG and correlation with intrahepatic HBV covalently-closed-circular DNA
2019-01-01 Gian Paolo Caviglia, Francesco Tandoi, Giulia Troshina, Lucio Boglione, Chiara Rosso, Elisabetta Bugianesi, Alessia Ciancio, Renato Romagnoli, Mario Rizzetto, Giorgio Maria Saracco, Antonina Smedile, Antonella Olivero
CROSS-SECTIONAL AND LONGITUDINAL EVALUATION OF ALPHA-FETOPROTEIN (AFP) AND PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II (PIVKA-II) IN PATIENTS WITH CIRRHOSIS OF VIRAL ETIOLOGY UNDER SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA (HCC)
2016-01-01 Caviglia, G.P.; Abate, M.L.; Bosco, C.; Gaia, S.; Olivero, A.; Rosso, C.; Carucci, P.; Ciancio, A.; Bugianesi, E.; Saracco, G.M.; Smedile, A.
Diagnostic accuracy of soluble sCD163 for the detection of severe fibrosis in patients with Non-Alcoholic Fatty Liver Disease
2019-01-01 Chiara Rosso, Ramy Younes, Rambabu Surabattula, Gian Paolo Caviglia, Diana Julie Leeming, Antonella Olivero, Maria Lorena Abate, Giorgio Maria Saracco, Amalia Gastaldelli, Detlef Schuppan, Elisabetta Bugianesi
DROPLET DIGITAL PCR APPLICATION FOR HEPATITIS DELTA VIREMIA QUANTIFICATION
2016-01-01 Olivero, A.; Abate, M.L.; Niro, G.; Caviglia, G.P.; Rosso, C.; Ciancio, A.; Fontana, R.; Smedile, A.; Rizzetto, M.; Saracco, G.M.
Efficacy of transjugular intrahepatic porto systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease
2020-01-01 Paola Ponzo, Martina Rizza, Daniela Campion, Ilaria Giovo, Michele Roma, Felice Rizzi, Alessandra Risso, Gian Paolo Caviglia, Giorgio Maria Saracco, Carlo Alessandria
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Prevalence of diabetes mellitus immunologic marker in patients with chronic hepatitis C before and after interferon therapy" | 1997 | Durazzo M;Mariani M.G;Biava MA;Clerico A;D'Errico N;Sacchi C;Tabone M;Saracco G;Rizzetto M;Pagano G. | |
| A NOVEL APPROACH FOR HEPATITIS DELTA VIRUS VIREMIA QUANTIFICATION BY DROPLET DIGITAL PCR ASSAY | 2016 | Olivero, A.; Abate, M.L.; Niro, G.; Caviglia, G.P.; Rosso, C.; Ciancio, A.; Fontana, R.; Smedile, A.; Rizzetto, M.; Saracco, G.M. | |
| Absolute quantification of intrahepatic HBV covalently-closed-circular DNA by droplet digital PCR | 2017 | Gian Paolo Caviglia; Maria Lorena Abate; Antonella Olivero; Chiara Rosso; Alessia Ciancio; Elisabetta Bugianesi; Giorgio Maria Saracco; Antonina Smedile | |
| Absolute quantification of intrahepatic hepatitis B virus covalently-closed-circular DNA by droplet digital PCR technology | 2017 | Caviglia, G.P.; Abate, M.L.; Olivero, A.; Rosso, C.; Ciancio, A.; Bugianesi, E.; Saracco, G.M.; Smedile, A. | |
| Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease | 2016 | Marietti, M.; Rosso, C.; Gaggini, M.; Saponaro, C.; Kazankov, K.; Buzzigoli, E.; Holler, H.J.; Caviglia, G.P.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Vilstrup, H.; George, J.; Gronbaek, H.; Gastaldelli, A.; Bugianesi, E. | |
| ALL ORAL SOFOSBUVIR-BASED ANTIVIRAL THERAPY IN LIVER TRANSPLANT RECIPIENTS AFFECTED BY MODERATE-SEVERE HEPATITIS C RECURRENCE: PREDICTORS OF VIRAL RESPONSE AND SURVIVAL | 2016 | Arese, D.; Martini, S.; Sacco, M.; Strona, S.; Cocchis, D.; Mirabella, S.; Rizza, G.; Ottobrelli, A.; Torrani-Cerenzia, M. R.; Balzola, F.; Magistroni, P.; Moschini, P.; Amoroso, A.; Salizzoni, M.; Rizzetto, M.; Romagnoli, R.; Saracco, G. M. | |
| Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation | 2016 | Gastaldelli, A.; Gaggini, M.; Rosso, C.; Della Latta, V.; Marietti, M.; Caviglia, G.; Carli, F.; Buzzigoli, E.; Ciociaro, D.; Abate, M.; Smedile, A.; Saracco, G.; Bugianesi, E. | |
| Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease | 2016 | Rosso, C.; Gaggini, M.; Saponaro, C.; Marietti, M.; Caviglia, G.P.; Carli, F.; Buzzigoli, E.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Gastaldelli, A.; Bugianesi, E. | |
| Angiotensin II type 1 receptor inhibition in early stage cirrhotic patients: Effects on portal pressure and liver fibrosis | 2004 | MARTINI S; ALESSANDRIA C; DEBERNARDI VENON W; MARZANO A; BIASI F; LEONE N; BARLETTI C; TODROS L; G. POLI; SARACCO G; RIZZETTO M | |
| Application of serum cytokeratin-19 fragments (CYFRA 21-1) in predicting the prognosis of patients with hepatocellular carcinoma | 2020 | Gian Paolo Caviglia, Antonella Olivero, Michela Ciruolo, Patrizia Carucci, Emanuela Rolle, Chiara Rosso, Maria Lorena Abate, Alessandra Risso, Ramy Younes, Antonina Smedile, Giorgio Maria Saracco, Elisabetta Bugianesi, Silvia Gaia | |
| Autoantibodies to glutamic acid decarboxilase (anti-GAD) in patients with chronic hepatitis C. | 1996 | R.Gambino; G.Saracco; G.M.Mariani; A.Maccagnani; M.A.Biava; R.Arcari; M.Cassader; M.Durazzo | |
| Autoimmunty in patients with chronic hepatitis type D and C | 1994 | Durazzo M,Schmidt E,Loges S,Michel G,Rosina F;Saracco G,Brunetto M-R,Smedile A,Scaglione L,Biava M-A,Borghesio E,Manns M-P,Rizzetto M | |
| Basal values and on treatment decline of hepatitis B core-related antigen are predictive of response to interferon therapy in chronic hepatitis D | 2018 | A. Olivero, G.P. Caviglia, A. Ciancio, C. Bosco, R. Fontana, G. Niro, M. Rizzetto, G. M. Saracco, A. Smedile. | |
| Basal values and on treatment decline of hepatitis B core-related antigen are predictive of response to interferon therapy in patients with chronic hepatitis D | 2018 | A. Olivero, G.P. Caviglia, A. Ciancio, C. Bosco, R. Fontana, G.A. Niro, M. Rizzetto , G.M. Saracco, A. Smedile | |
| Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD | 2018 | C. Rosso, R. Younes, M. Eslam, FW. Chen, M. Cucco, M. Gaggini, S. Coulter, F. Carli, C. Barbieri, V. della Latta, M.L. Abate, GM. Saracco, A. Gastaldelli, J. George, E. Bugianesi | |
| Characterization of a novel chemiluminescent enzyme immunoassay for the quantitation of antibodies to hepatitis B core antigen class IgG and correlation with intrahepatic HBV covalently-closed-circular DNA | 2019 | Gian Paolo Caviglia, Francesco Tandoi, Giulia Troshina, Lucio Boglione, Chiara Rosso, Elisabetta Bugianesi, Alessia Ciancio, Renato Romagnoli, Mario Rizzetto, Giorgio Maria Saracco, Antonina Smedile, Antonella Olivero | |
| CROSS-SECTIONAL AND LONGITUDINAL EVALUATION OF ALPHA-FETOPROTEIN (AFP) AND PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II (PIVKA-II) IN PATIENTS WITH CIRRHOSIS OF VIRAL ETIOLOGY UNDER SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA (HCC) | 2016 | Caviglia, G.P.; Abate, M.L.; Bosco, C.; Gaia, S.; Olivero, A.; Rosso, C.; Carucci, P.; Ciancio, A.; Bugianesi, E.; Saracco, G.M.; Smedile, A. | |
| Diagnostic accuracy of soluble sCD163 for the detection of severe fibrosis in patients with Non-Alcoholic Fatty Liver Disease | 2019 | Chiara Rosso, Ramy Younes, Rambabu Surabattula, Gian Paolo Caviglia, Diana Julie Leeming, Antonella Olivero, Maria Lorena Abate, Giorgio Maria Saracco, Amalia Gastaldelli, Detlef Schuppan, Elisabetta Bugianesi | |
| DROPLET DIGITAL PCR APPLICATION FOR HEPATITIS DELTA VIREMIA QUANTIFICATION | 2016 | Olivero, A.; Abate, M.L.; Niro, G.; Caviglia, G.P.; Rosso, C.; Ciancio, A.; Fontana, R.; Smedile, A.; Rizzetto, M.; Saracco, G.M. | |
| Efficacy of transjugular intrahepatic porto systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease | 2020 | Paola Ponzo, Martina Rizza, Daniela Campion, Ilaria Giovo, Michele Roma, Felice Rizzi, Alessandra Risso, Gian Paolo Caviglia, Giorgio Maria Saracco, Carlo Alessandria |